Response to: ‘reporting of potential immunogenicity with biologic drugs: clarity and accuracy required’ by Moots et al

Emery, P, Vencovský, J and Ghil, J (2016) Response to: ‘reporting of potential immunogenicity with biologic drugs: clarity and accuracy required’ by Moots et al. Annals of the Rheumatic Diseases, 75 (5). e25. ISSN 0003-4967

Metadata

Authors/Creators:
  • Emery, P
  • Vencovský, J
  • Ghil, J
Copyright, Publisher and Additional Information: (c) Article author (or their employer), 2016. Produced by BMJ Publishing Group Ltd (& EULAR) under licence. This is an author produced version of a paper published in Annals of the Rheumatic Diseases. Uploaded in accordance with the publisher's self-archiving policy.
Keywords: DMARDs (biologic), Rheumatoid Arthritis, Autoantibodies
Dates:
  • Accepted: 25 January 2016
  • Published (online): 17 February 2016
  • Published: May 2016
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Clinical Musculoskeletal Medicine (LIRMM) (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 11 Feb 2016 12:45
Last Modified: 24 Jan 2018 17:28
Published Version: http://doi.org/10.1136/annrheumdis-2016-209203
Status: Published
Publisher: BMJ Publishing Group
Identification Number: https://doi.org/10.1136/annrheumdis-2016-209203

Export

Statistics


CORE (COnnecting REpositories)